Brokerages forecast that AAC Holdings Inc (NYSE:AAC) will announce $0.06 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for AAC’s earnings, with estimates ranging from ($0.13) to $0.25. AAC posted earnings per share of $0.10 in the same quarter last year, which would suggest a negative year over year growth rate of 40%. The company is scheduled to issue its next earnings report on Wednesday, February 20th.
According to Zacks, analysts expect that AAC will report full year earnings of $0.20 per share for the current financial year, with EPS estimates ranging from $0.01 to $0.39. For the next fiscal year, analysts forecast that the business will post earnings of $0.42 per share, with EPS estimates ranging from ($0.10) to $0.94. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover AAC.
AAC (NYSE:AAC) last released its quarterly earnings results on Tuesday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.32). The company had revenue of $77.47 million for the quarter, compared to the consensus estimate of $84.21 million. AAC had a positive return on equity of 4.21% and a negative net margin of 10.20%. The business’s revenue was down 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.12 EPS.
AAC stock traded up $0.12 during midday trading on Tuesday, hitting $2.15. 507,844 shares of the company’s stock were exchanged, compared to its average volume of 469,174. The company has a current ratio of 2.17, a quick ratio of 2.17 and a debt-to-equity ratio of 2.58. The firm has a market cap of $52.89 million, a PE ratio of 3.58 and a beta of 1.42. AAC has a one year low of $1.70 and a one year high of $12.96.
In related news, Director Darrell S. Freeman bought 25,000 shares of the stock in a transaction that occurred on Thursday, November 29th. The shares were acquired at an average price of $2.19 per share, with a total value of $54,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael Nanko purchased 21,000 shares of the stock in a transaction on Friday, November 30th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $45,780.00. Following the transaction, the insider now owns 69,700 shares of the company’s stock, valued at $151,946. The disclosure for this purchase can be found here. 37.30% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in AAC. Acadian Asset Management LLC increased its position in AAC by 128.1% during the second quarter. Acadian Asset Management LLC now owns 64,270 shares of the company’s stock worth $602,000 after buying an additional 36,090 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in AAC by 124.8% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 80,775 shares of the company’s stock valued at $757,000 after purchasing an additional 44,850 shares during the period. Bowling Portfolio Management LLC acquired a new stake in AAC in the second quarter valued at $759,000. Monarch Partners Asset Management LLC increased its holdings in AAC by 218.7% in the second quarter. Monarch Partners Asset Management LLC now owns 69,500 shares of the company’s stock valued at $651,000 after purchasing an additional 47,690 shares during the period. Finally, Spark Investment Management LLC increased its holdings in AAC by 11.9% in the second quarter. Spark Investment Management LLC now owns 82,600 shares of the company’s stock valued at $773,000 after purchasing an additional 8,800 shares during the period. 66.22% of the stock is currently owned by hedge funds and other institutional investors.
AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.
Recommended Story: Fiduciary
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.